SCHEMBL4339550

SCHEMBL4339550

CC(C)OC(Cc1cccc(CNC(=O)OCc2ccccc2Cl)c1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.46
PPARA Q07869 2/20 0.46
NPC1 O15118 1/20 0.42
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
EPHX1 P07099 2/20 0.41
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNA5 P22460 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
TACR1 P25103 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328023 0.90 GAA (0.44) PPARGPPARALMNATSHRSMN1; SMN2
SCHEMBL4329105 0.90 PPARA (0.40) PPARGPPARANPC1ALDH1A1TSHR
SCHEMBL4329108 0.90 PPARA (0.40) PPARGPPARANPC1ALDH1A1TSHR
SCHEMBL4328125 0.90 TSHR (0.40) PPARGPPARATSHRSMN1; SMN2
SCHEMBL4337158 0.86 TSHR (0.52) PPARGPPARANPC1ALDH1A1TSHR
SCHEMBL13810957 0.86 TSHR (0.52) PPARGPPARANPC1ALDH1A1TSHR
SCHEMBL4339657 0.86 PLAU (0.39) PPARGPPARA
SCHEMBL4339256 0.86 PPARG (0.46) PPARGPPARAALDH1A1HPGDTACR1
SCHEMBL4329078 0.86 PPARA (0.45) PPARGPPARATSHRSMN1; SMN2
SCHEMBL4339654 0.86 PLAU (0.39) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PPARG 379/4885PPARA 339/4885NPC1 603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.